Advances in Knowledge, Diagnosis, and Treatment of Tuberculosis Infection
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 188
Special Issue Editor
Interests: infectious diseases; mycobacteria; M. tuberculosis complex; latent tuberculosis infection; nontuberculous mycobacteria; epidemiology; genotyping, diagnostics and drug resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
One-fourth of the world’s population is estimated to be infected with Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). Most people infected with M. tuberculosis contain the infection within their bodies, leading to a condition previously known as dormant or latent TB, which is now referred to as TB infection (TBI). These individuals do not develop illness or symptoms of the disease and cannot transmit their infection. However, TBI can reactivate and cause TB disease in 5-10% of infected individuals. TB disease is one of the leading causes of death worldwide and can be transmitted to the community. Therefore, a concerted effort to prevent and control TB is needed to help meet the ambitious target of ending the TB epidemic globally by 2035. These efforts include screening and treating individuals with TBI. Doing so will help reduce the pool of individuals harboring M. tuberculosis who are at risk of developing TB disease and spreading the infection.
This Special Issue seeks to highlight diverse efforts worldwide aimed at better understanding the barriers and enablers of TB infection screening and treatment to inform the development and implementation of appropriate public health interventions. We welcome submissions of original research and review manuscripts that cover any aspects of the above-listed topics.
Dr. Isdore Chola Shamputa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- TB infection
- TB disease
- screening
- treatment
- Mycobacterium tuberculosis
